Y. de Keyzer

发表

RT-PCR analysis of corticotroph-associated genes expression in carcinoid tumours in the ectopic-ACTH syndrome.

X. Bertagna, C. Carrière, Y. Keyzer, 2006, European journal of endocrinology.

TMEM126A is a mitochondrial located mRNA (MLR) protein of the mitochondrial inner membrane.

A. Munnich, T. Delaveau, F. Devaux, 2013, Biochimica et biophysica acta.

Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor.

X. Bertagna, X. Marchandise, J. Epelbaum, 1994, The Journal of clinical endocrinology and metabolism.

High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta

D. Cabrol, X. Bertagna, J. Coste, 1999, Clinical endocrinology.

Overexpression of vasopressin (V3) and corticotrophin‐releasing hormone receptor genes in corticotroph tumours

X. Bertagna, F. Lenne, C. Beldjord, 1998, Clinical endocrinology.

High expression of the POU factor Brn3a in aggressive neuroendocrine tumors.

X. Bertagna, M. Leblond-Francillard, Y. de Keyzer, 1997, The Journal of clinical endocrinology and metabolism.

The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.

H. Vaudry, X. Bertagna, F. Lenne, 1996, The Journal of clinical investigation.

Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries.

X. Bertagna, A. Kahn, F. Lenne, 1985, The Journal of clinical investigation.

Proopiomelanocortin gene expression in normal and tumoral human lung.

D. Vieau, X. Bertagna, A. Kahn, 1991, The Journal of clinical endocrinology and metabolism.

Pituitary-like proopiomelanocortin transcripts in human Leydig cell tumors.

D. Vieau, X. Bertagna, A. Kahn, 1990, The Journal of clinical investigation.

Overexpression of the V3 Vasopressin Receptor in Transgenic Mice Corticotropes Leads to Increased Basal Corticosterone

X. Bertagna, D. Bucchini, J. Epelbaum, 2002, Journal of neuroendocrinology.

Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors.

G. Arnaldi, X. Bertagna, J. Luton, 1998, The Journal of clinical endocrinology and metabolism.

PTH mRNA transcription analysis in infantile tumors associated with hypercalcemia

C. Nezelof, G. Cournot, M. Rousseau-Merck, 1988, Cancer.

Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood.

R. Houtkooper, Ann Saada, A. Shaag, 2008, American journal of human genetics.

Characterization of proopiomelanocortin transcripts in human nonpituitary tissues.

X. Bertagna, A. Kahn, J. Luton, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Variable modes of proopiomelanocortin gene transcription in human tumors.

X. Bertagna, A. Kahn, J. Luton, 1989, Molecular endocrinology.

V3 vasopressin receptor and corticotropic phenotype in pituitary and nonpituitary tumors.

X. Bertagna, F. Lenne, C. Auzan, 1997, Hormone research.

Functional analysis of the human pro-opiomelanocortin promoter in the small cell lung carcinoma cell line DMS-79.

X. Bertagna, F. Lenne, M. Raffin-Sanson, 1995, Journal of molecular endocrinology.

Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: in vivo and in vitro studies.

H. Vaudry, X. Bertagna, E. Clauser, 1995, The Journal of clinical endocrinology and metabolism.

Cardiomyopathies in propionic aciduria are reversible after liver transplantation.

D. Rabier, P. de Lonlay, G. Touati, 2010, The Journal of pediatrics.

Ectopic ACTH Cushing’s Syndrome: V3 Vasopressin Receptor But Not CRH Receptor Gene Expression in a Pulmonary Carcinoid Tumor

M. Dusmet, A. Bischof-Delaloye, S. Gebhard, 1998, Hormone Research in Paediatrics.

Risk assessment of acute vascular events in congenital disorder of glycosylation type Ia.

A. Munnich, N. Boddaert, F. Brunelle, 2008, Molecular genetics and metabolism.

The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.

J. Corvol, X. Bertagna, J. Luton, 1995, The Journal of clinical endocrinology and metabolism.

Clinical and biochemical heterogeneity associated with fumarase deficiency

A. Munnich, N. Boddaert, T. Frebourg, 2011, Human mutation.

Vasopressin receptors modulate the pharmacological phenotypes of Cushing's syndrome.

G. Arnaldi, X. Bertagna, E. Clauser, 1998, Endocrine research.

Cloning and characterization of the human V3 pituitary vasopressin receptor

X. Bertagna, F. Lenne, M. Thibonnier, 1994, FEBS letters.

Identification of a novel rat hepatic gene induced early by insulin, independently of glucose.

J. Girard, J. Decaux, M. Asfari, 2005, The Biochemical journal.

Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions.

X. Bertagna, M. Raffin-Sanson, Y. Keyzer, 2003, European journal of endocrinology.

Development of liver disease despite mannose treatment in two patients with CDG-Ib.

P. de Lonlay, L. Galmiche, F. Jaubert, 2008, Molecular genetics and metabolism.

Pro-opiomelanocortin gene expression in human phaeochromocytomas.

X. Bertagna, A. Kahn, J. Luton, 1989, Journal of molecular endocrinology.

Nucleotide sequence and structural organization of the human vasopressin pituitary receptor (V3) gene.

X. Bertagna, F. Lenne, P. René, 2000, Gene.

LPIN1 gene mutations: a major cause of severe rhabdomyolysis in early childhood

Wolfgang Müller-Felber, Arnold Munnich, Laurence Hubert, 2010, Human mutation.

Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism.

C. Bellanné-Chantelot, Y. Aigrain, P. de Lonlay, 2008, The Journal of clinical endocrinology and metabolism.

Role for NF-kappa B in mediating the effects of hyperoxia on IGF-binding protein 2 promoter activity in lung alveolar epithelial cells.

E. Nabeyrat, S. Corroyer, V. Cazals, 1999, Biochimica et biophysica acta.

Liver hepatoblastoma and multiple OXPHOS deficiency in the follow-up of a patient with methylmalonic aciduria.

A. Munnich, C. Guyot, D. Rabier, 2008, Molecular genetics and metabolism.

Identification of genes associated with the corticotroph phenotype in bronchial carcinoid tumors.

X. Bertagna, L. Pascual-Le Tallec, É. Dulmet, 2002, The Journal of clinical endocrinology and metabolism.

Dihydrolipoamide dehydrogenase deficiency: a still overlooked cause of recurrent acute liver failure and Reye-like syndrome.

D. Rabier, P. de Lonlay, A. Brassier, 2013, Molecular genetics and metabolism.

Combination of lipid metabolism alterations and their sensitivity to inflammatory cytokines in human lipin-1-deficient myoblasts.

A. Smahi, A. Munnich, G. Carman, 2013, Biochimica et biophysica acta.

Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor.

X. Bertagna, E. Clauser, P. René, 1999, Journal of molecular endocrinology.

Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors.

X. Bertagna, F. Lenne, Y. de Keyzer, 1997, European journal of endocrinology.

Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia)

S. Lyonnet, P. de Lonlay, D. Bonnet, 2009, Journal of Medical Genetics.

Mutations in UCP2 in Congenital Hyperinsulinism Reveal a Role for Regulation of Insulin Secretion

C. Bellanné-Chantelot, P. de Lonlay, L. Hubert, 2008, PloS one.

Paraneoplastic Cushing syndrome due to adrenal neuroblastoma.

J. Weill, B. Nelken, Y. de Keyzer, 2000, Medical and pediatric oncology.

Chromosomal localization of the human V3 pituitary vasopressin receptor gene (AVPR3) to 1q32.

R. Berger, T. Bienvenu, J. Derré, 1995, Genomics.

Chapter 27 The vasopressin receptor of corticotroph pituitary cells

P. René, Y. Keyzer, Y. de Keyzer, 2002 .